Huons Meditech showcases flagship devices at Hospitalar 2024 in Brazil
Huons Meditech, a Korean medical device manufacturer under Huons Group, said on Monday it participated in Hospitalar 2024, the largest medical device trade show in Latin America, held from May 21-24 in São Paulo, Brazil.
Leading medical device and healthcare professionals in South America gathered at Hospitalar 2024 where the latest medical technologies and products were promoted.
Huons Meditech said it displayed its key medical devices at the event to solidify its presence in the Latin American market.
The Korean company’s flagship products showcased at Hospitalar 2024 include ASADAL-M1, a magnetic extracorporeal shock wave lithotripsy device certified by the FDA in the U.S. and CE in Europe, DermaShine Pro, an automated drug injection device, and HUEN DR 02, an endoscopic sterilizer. Huons Meditech also explored new business opportunities through multiple business meetings and networking at the event.
ASADAL-M1, the lithotripsy device that attracted keen attention from participants, is based on electromagnetic extracorporeal shock wave technology. It enables a non-invasive procedure with a safe and high rate of urinary stone crushing, according to Huons Meditech. This non-invasive method offers shorter procedure times and safer outcomes, compared to traditional surgery. Patients can undergo treatment and leave on the same day.
“We are very pleased to participate in Hospitalar, the largest exhibition in South America, to introduce the proven safety and effectiveness of ASADAL-M1 to the Brazilian and South American markets,” said Lee Jin-suk, CEO of Huons Meditech. “Based on our participation in this exhibition, we will do our best to strengthen our cooperation with local partners and enhance our competitiveness in the global market.”
To expand its global reach, Huons Meditech plans to participate in the Florida International Medical Expo (FIME), the largest international medical trade event in the Americas, on June 19-21, in Miami, the U.S.